Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo — Mounjaro (tirzepatide) is a once-weekly injection, and taking two doses in any seven-day period is not how the medicine is licensed or prescribed. Doubling up does not accelerate weight loss; it significantly raises the risk of serious side effects. If you've missed a dose, forgotten when you last injected, or simply wondered whether more means faster, this page works through exactly what to do and why the weekly schedule exists. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber decides the dose that is clinically right for you, based on your full health picture — not a fixed calendar you can adjust yourself.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide has a half-life of roughly five days. That means when you inject on, say, a Monday, a meaningful amount of the medicine is still circulating in your bloodstream the following Monday when your next dose is due. The weekly schedule is calibrated around this, each injection adds to a steady background level rather than starting from scratch.
Inject a second time within the same week and you are not getting a top-up; you are adding a full clinical dose on top of one that has not cleared. Blood-glucose effects, GI effects and cardiovascular effects all amplify accordingly. The NHS tirzepatide medicines page is clear that the injection is given once weekly, on the same day each week where possible, that consistency is deliberate, not arbitrary.
It also matters that the starting dose of 2.5 mg is a tolerability step, not a therapeutic ceiling. Its job is to let your digestive system adjust before the prescriber moves things forward. If you have been wondering whether you can take 2 doses of Mounjaro to speed things along, the short answer is no, rushing that timeline by injecting twice in a week does not move you faster along the dose ladder; it risks pushing you off it entirely through adverse effects that require stopping treatment.
This is probably the most common reason people search this question. You injected at some point last week, you're not certain of the exact day, and you're wondering whether a second shot would catch things up. It won't, and the fix is simpler than that.
The standard guidance, set out in the Mounjaro Patient Information Leaflet, is: if fewer than four days have passed since your missed dose, inject as soon as you remember, then continue on your usual day the following week. If more than four days have passed, skip that missed dose entirely and inject on your next scheduled day. Two injections are never the answer. Always refer to the leaflet in your pack for the exact wording, and call your prescriber or the nume aftercare team if you are genuinely uncertain, that is what the 7-day support is there for.
A practical note: many people find it helps to link their injection day to something fixed, the pen lives in the fridge door and goes in every Sunday morning before the kettle boils. A phone reminder set to repeat weekly is equally reliable. The mechanism matters less than the consistency.
Accidental double-dosing does happen. If you have already injected twice in a week (perhaps because two carers gave the injection independently, or a confused pen was mistaken for an unused one) the response depends on how you feel.
Mild nausea and discomfort are likely and may settle over a day or two with small meals and steady hydration. Seek urgent medical help if you experience severe or persistent stomach pain that radiates towards the back, repeated vomiting preventing you from keeping fluids down, signs of a serious allergic reaction, or any symptoms that feel out of proportion to previous side effects. The MHRA's January 2026 Drug Safety Update specifically flagged acute pancreatitis as a serious but uncommon risk with GLP-1 medicines, severe stomach pain is the key warning sign and should not be waited out. Report any suspected adverse reaction through the MHRA Yellow Card scheme.
If in doubt, call 111 or attend your nearest urgent treatment centre. Do not wait to see whether it settles.
Some people arrive at this question from a different angle: not a missed dose, but a feeling that their current dose is no longer doing much and they want to move faster. That instinct is understandable. Our guidance on whether you can take two doses of 2.5 Mounjaro explains in detail why increasing frequency is not how Mounjaro's dose escalation works, strength goes up (from 2.5 mg through 5, 7.5, 10, 12.5 to 15 mg), not frequency. Each step is assessed by a prescriber, typically after four weeks at the current dose, based on tolerability and clinical response.
You can read more about what each dose step involves on the Mounjaro 5 mg overview or the wider Mounjaro treatment page, which covers the full licensed dose range. If you feel your dose is not working as expected, the right move is a clinical conversation, not a second injection. For anyone still weighing up whether taking 2 doses of 2.5 Mounjaro is an option, questions about what the treatment costs across dose steps are also covered on the Mounjaro cost page.
Our prescribers review every repeat order before it is dispensed, there is no auto-renewal, and no dose increase goes out without clinical reassessment. That review exists precisely because individual responses vary and the right dose at month three may not be the right dose at month six. Our clinical team is available to discuss concerns between orders too.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.